Design and synthesis of novel substituted pyrazole as small molecule inhibitor of cytochrome P450 CYP121A1
Discovering new drugs with novel targets is vital for the success of treatment of tuberculosis as antibiotic resistance is increasing among the TB population. Mycobacterium tuberculosis cytochrome P450 CYP121A1 is a promising drug target for the treatment of tuberculosis owing to its essential role...
Main Authors: | Mitali Jasani, Laxman Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Results in Chemistry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211715622004581 |
Similar Items
-
Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of <i>Mycobacterium tuberculosis</i>
by: Leena Hussein Bajrai, et al.
Published: (2022-09-01) -
CYP141 gene: A New approach for
Mycobacterium Tuberculosis Identification
by: masoud keikha
Published: (2017-12-01) -
Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
by: Sergey Bukhdruker, et al.
Published: (2020-10-01) -
Generation of new inhibitors of selected cytochrome P450 subtypes– In silico study
by: Tomasz Danel, et al.
Published: (2022-01-01) -
Synthesis, DFT, Molecular docking Analysis and Antibacterial, Antioxidant Activities of tri-substituted pyrazoles
by: Golea Lynda
Published: (2021-07-01)